References
- Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–574.
- Cerdá M, Krawczyk N, Hamilton L, Rudolph KE, Friedman SR, Keyes KM. A critical review of the social and behavioral contributions to the overdose epidemic. Annu Rev Public Health. 2021;42(1):27.
- Sanchez ZM. Binge drinking among young Brazilians and the promotion of alcoholic beverages: a public health concern. Epidemiol Serv Saude. 2017;26(1):195–198.
- Sureda X, Villalbí JR, Espelt A, Franco M. Living under the influence: normalisation of alcohol consumption in our cities. Gac Sanit. 2017;31(1):66–68.
- De Boni RB, Pechansky F, de Vasconcellos MT, Bastos FI. Have drivers at alcohol outlets changed their behavior after the new traffic law? Braz J Psychiatry. 2014;36(1):11–15.
- Krawczyk N, Greene MC, Zorzanelli R, Bastos FI. Rising trends of prescription opioid sales in contemporary Brazil, 2009–2015. Am J Public Health. 2018;108(5):666–668.
- Krawczyk N, Silva P. L d N, De Boni RB, et al. Non-medical use of opioid analgesics in contemporary Brazil: findings from the 2015 Brazilian National Household Survey on Substance Use. Glob Public Health. 2020;15(2):299–306.
- Orlandi P, Noto AR. [Misuse of benzodiazepines: a study among key informants in São Paulo city]. Rev Lat Am Enfermagem. 2005;13(SPE):896–902.
- Nappo S, Carlini EA. Preliminary finding: consumption of benzodiazepines in Brazil during the years 1988 and 1989. Drug Alcohol Depend. 1993;33(1):11–17.
- Zorzanelli RT, Giordani F, Guaraldo L, et al. Consumption of the benzodiazepine clonazepam (Rivotril®) in Rio de Janeiro State, Brazil, 2009–2013: an ecological study. Cien Saude Colet. 2019;24(8):3129–3140.
- Morley KI, Ferris JA, Winstock AR, Lynskey MT. Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data. Pain. 2017;158(6):1138–1144.
- Witkiewitz K, Vowles KE. Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review. Alcohol Clin Exp Res. 2018;42(3):478–488.
- McHugh RK, Votaw VR, Taghian NR, Griffin ML, Weiss RD. Benzodiazepine misuse in adults with alcohol use disorder: prevalence, motives and patterns of use. J Subst Abuse Treat. 2020;117:108061.
- Votaw VR, Witkiewitz K, Valeri L, Bogunovic O, McHugh RK. Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders. Addict Behav. 2019;88:48–55.
- Schmitz A. Benzodiazepine use, misuse, and abuse: a review. Ment Health Clin. 2016;6(3):120–126.
- Jones CM, Paulozzi LJ, Mack KA. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths — United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(40):881–885. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584609/. Accessed July 24, 2020.
- Silva Pl do N, Vasconcellos MTL, De Boni RB, et al. First Reproducible Nationwide Survey on substance use in Brazil: survey design and weighting. In: Alexandria, VA: American Statistical Association, Proceedings of the Survey Research Methods Section, 2018. 2018:2507–2514.
- De Boni RB, de Vasconcellos MTL, Silva PN, et al. Reproducibility on science: challenges and advances in Brazilian alcohol surveys. Int J Drug Policy. 2019;74:285–291.
- E-Doc Sistemas Médicos. E-Doc Portal de Sistemas Médicos. http://www.edoc.med.br/def.php. Published 2006. Accessed August 24, 2020.
- Reyes JC, Pérez CM, Colón HM, Dowell MH, Cumsille F. Prevalence and patterns of polydrug use in Latin America: analysis of population-based surveys in six countries. Rev Eur Stud. 2013;5(1):10–18.
- Salom CL, Betts KS, Williams GM, Najman JM, Alati R. Predictors of comorbid polysubstance use and mental health disorders in young adults–a latent class analysis. Addiction. 2016;111(1):156–164.
- He H, Tang W, Wang W, Crits-Christoph P. Structural zeroes and zero-inflated models. Shanghai Arch Psychiatry. 2014;26(4):236–242.
- Lambert D. Zero-inflated Poisson regression, with an application to defects in manufacturing. Technometrics. 1992;34(1):1–14.
- Famoye F, Singh KP. Zero-Inflated Generalized Poisson Regression Model with an Application to Domestic Violence Data. Vol 4; 2006.
- Dai L, Sweat MD, Gebregziabher M. Modeling excess zeros and heterogeneity in count data from a complex survey design with application to the demographic health survey in sub-Saharan africa. Stat Methods Med Res. 2018;27(1):208–220.
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499.
- Secretaria Nacional Antidrogas (SENAD). II Levantamento Domiciliar Sobre o Uso de Drogas Psicotrópicas No Brasil – 2005 – CEBRID; 2005. https://www.cebrid.com.br/ii-levantamento-domiciliar-2005/. Accessed May 7, 2019.
- Center for Behavioral Health Statistics and Quality. Results from the 2015 National Survey on Drug Use and Health: detailed tables prevalence estimates. 2015 Natl Surv Drug Use Heal. 2016:209. http://www.samhsa.gov/data/population-data-nsduh/reports?tab=38.
- World Health Organization. Global Status Report on Alcohol and Health 2018; 2018. https://www.who.int/publications/i/item/9789241565639. Accessed April 23, 2021.
- Tardelli VS, Fidalgo TM, Santaella J, Martins SS. Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: differences by insurance status. Drug Alcohol Depend. 2019;204:107573.
- Kapczinski F, Amaral OB, Madruga M, Quevedo J, Busnello JV, De Lima MS. Use and misuse of benzodiazepines in Brazil: a review. Subst Use Misuse. 2001;36(8):1053–1069.
- Connor JP, Gullo MJ, White A, Kelly AB. Polysubstance use: diagnostic challenges, patterns of use and health. Curr Opin Psychiatry. 2014;27(4):269–275.
- Betts KS, Chan G, McIlwraith F, et al. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies. Addiction. 2016;111(7):1214–1223.
- Hedden SL. Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health; 2015.
- Smith GW, Farrell M, Bunting BP, Houston JE, Shevlin M. Patterns of polydrug use in Great Britain: findings from a national household population survey. Drug Alcohol Depend. 2011;113(2–3):222–228.
- Quek LH, Chan GCK, White A, et al. Concurrent and simultaneous polydrug use: latent class analysis of an Australian nationally representative sample of young adults. Front Public Heal. 2013;1(Nov):61.
- de Oliveira LG, Alberghini DG, dos Santos B, de Andrade AG. Polydrug use among college students in Brazil: a nationwide survey. Braz J Psychiatry. 2013;35(3):221–230.
- Maia LO, Daldegan-Bueno D, Fischer B. Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators. Subst Abus Treat Prev Policy. 2021;16(1):1–10.